II. Indications
- Acute medical condition
-
Medication Compliance
- Opioid, Benzodiazepine or other controlled substance prescription monitoring
- Chemical Dependency Rehabilitation
- Participation
- Employment (e.g. transportation licensing for commerical drivers, pilots)
- Military participation
- Sports participation
III. Precautions
- Urine toxicology utility has been markedly reduced by the growing use of synthetics
- Urine toxicology misses many standard substances
- Does not detect the most frequently used Benzodiazepines (Alprazolam, Clonazepam, Lorazepam)
- Variable detection of MDMA (Ecstasy)
- Does not detect semi-synthetic and synthetic Opioids
- Positive drug screen does not exclude serious other causes for Altered Mental Status
- Meningitis or Intracranial Hemorrhage may coexist with a positive Urine Drug Screen
IV. Efficacy
- Random urine drug testing may decrease Illicit Drug use in those on Chronic Opioid therapy
V. Protocol: Assess validity of real urine sample
- Urine Temperature (within 4 minutes of voiding): 90 F (32.2 C) to 100 F (37.7 C)
- Urine pH: 4.5 to 8.5 (some facilities use pH 3.0-11.0)
- Urine Creatinine: 20 mg/dl or greater (otherwise artificially diluted)
- Nitrite concentration <500 mg/dl (<4.2 mmol/L)
- Sample size 30 ml or more
VI. Protocol: Prevent urine sample tampering
- Remove outer clothing (jackets, sweatshirts, hat)
- Remove any items in urine collection area that could be used to tamper with sample (bleach, vinegar, soap, ammonia, salt)
- Remove any items from pockets
- Do not allow briefcases, backpacks, purses and other similar items in collection area
- Patient should wash and dry hands with liquid soap under observation
- Add bluing agent to toilet and turn off water to the testing area
- Observe the actual collection and use chain of custody forms to accompany the sample
- Consider split sample collections with tamper resistant containers
VII. Protocol: Urine Drug Testing Frequency in controlled substance prescription monitoring
- Predictors of misuse
- Mental health disorder
- Substance Use Disorder
- Prior Opioid misuse
- Opioid dose >120 mg Morphine Equivalents
- Lost prescriptions
- Multiple requests for early refills
- Opioid prescriptions from multiple physicians
- Unauthorized dose increases
- Intoxication at visit
- Low risk of misuse
- Urine drug test every 6 to 12 months
- Moderate risk of misuse
- Urine drug test every 3 to 6 months
- High risk of misuse
- Urine drug test every 1 to 3 months
- References
- WSAMDG Guideline on Prescribing Opioids for Pain
VIII. Labs
- Screening Basic Qualitative Urine Immunoassay (typically 5 Drug Class)
- Reference Lab Confirmatory testing (gas chromatography or high performance liquid chromatography)
- Indicated for positive results and unexpected negative results
- Specific immunoassay examples
- Synthetic and Semisynthetic Opioids (e.g. Methadone, Buprenorphine, Oxycodone, Fentanyl)
- Benzodiazepines not found on immunoassay (e.g. Alprazolam, Lorazepam, Clonazepam)
- Synthetic Cannabinoids (e.g. K2, Spice)
- Cathinones (bath salts)
- Hallucinogens (N-Bomb)
IX. Preparations: Sedatives and Hypnotics
-
Alcohol (Ethanol)
- Detection Positive: 3 to 10 hours
-
Barbiturates
- Detection
- Short-Actings agents: 1-2 days
- Long-acting agents (e.g. Phenobarbital): 21 days
- Causes: False Positive tests
- Detection
-
Benzodiazepines
- See Benzodiazepine Metabolism
- Many hospital-based Urine Drug Screens only detect Oxazepam and its precursors (Diazepam, Librium)
- These Urine Drug Screens miss Alprazolam, Clonazepam, Lorazepam, Flunitrazepam (Rohypnol)
- Detection (high doses may be detectable up to 6 weeks)
- Short-acting agents (e.g. Lorazepam, Alprazolam): 3-5 days
- Long acting agents (Clonazepam, Diazepam): 30 days
- Zolpidem (Ambien): 1 to 5 days
- Analytes
- Alpha-hydroxyalprazolam
- 7-Aminoclonazepam
- Oxazepam
- Causes: False Positive tests
X. Preparations: Stimulants - Cocaine
- Detection Direct: 5 hours
- Analytes (metabolites): Benzoylecgonine, Ecgonine methyl ester
- Detection Metabolites: 2-4 days (may persist as long as 8 days with heavy use)
- Causes: False Positive tests
- Coca leaf tea
- Topical Anesthetics containing Cocaine
XI. Preparations: Stimulants - Bath Salts
- Not detected by routine Urine Drug Screening
- Liquid and gas chromatography-mass spectrometry may detect bath salts and other synthetics
- Not widely available, expensive and prolonged test turn-around time
XII. Preparations: Stimulants - Amphetamine or Methamphetamine
- Positive: 1 to 3 days
- Detects Amphetamine at 500 ng/ml in Urine Drug Screen (and 250 ng/ml in confirmatory testing)
- Detects Methamphetamine at 250 ng/ml in Urine Drug Screen
- Decreased urine Test Sensitivity with large bicarbonate ingestions
- May also detect MDMA
- Causes: False Positive tests
- Amantadine
- Benzphetamine (Regimex)
- Brompheniramine
- Bupropion (Wellbutrin)
- Chlorpromazine
- Chloroquine
- Desipramine
- Doxepin
- Fluoxetine (Prozac)
- Labetalol
- Levomethamphetamine (OTC nasal Decongestant sprays)
- Methylphenidate (Ritalin)
- MDMA
- Phentermine
- Phenylephrine
- Phenylpropanolamine
- Promethazine (Phenergan)
- Pseudoephedrine
- Ranitidine (Zantac)
- Selegiline
- Thioridazine
- Trazodone
- Trimethobenzamide (Tigan)
- Trimipramine (Surmontil)
- Venlafaxine (Effexor)
- Vicks Inhaler
XIII. Preparations: Opioids
- See Opioid Metabolism
- Tests
- Gas chromatography: Detects all Opioids
- Enzyme linked assays:
- Reliably detects naturally occurring Opiates (Opioid subset)
- Misses semi-synthetic Opioids (structurally similar to Opiates)
- Hydrocodone
- Oxycodone
- Hydromorphone
- Oxymorphone
- Fentanyl
- Misses synthetic Opioids
- Preparations
- Codeine
- Detection Positive: 1 to 2 days
- May be detected as analytes: Morphine, Hydromorphone
- Heroin (detected as Morphine on less specific testing)
- Hydromorphone (Dilaudid)
- Detection Positive: 1 to 2 days (up to 4 days in some cases)
- Methadone (Dolophine)
- Detection Positive: 3 to 4 days (up to 14 days in some cases)
- Analytes: 2-ethylidene-1,5-dimethyl-3, 3-Diphenylpyrrolidine
- Propoxyphene (Darvon)
- Detection
- Direct: 6 hours
- Metabolites: 6 to 48 hours
- Detection
- Fentanyl
- Detection positive: 2 to 3 days (up to 4 days in some cases)
- Analytes: Norfentanyl
- Hydrocodone (e.g. Vicodin)
- Dectection positive: 1 to 2 days
- May be detected as Hydromorphone (metabolite)
- Oxycodone (e.g. Percocet)
- Detection positive: 1 to 1.5 days (up to 3 days for controlled release)
- Analytes: Noroxycodone, noroxymorphone, Oxycodone, oxymorphone
- Oxymorphone (Opana)
- Detection positive: 1.5 to 2.5 days (up to 4 days for controlled release)
- Analytes: Noroxymorphone
- Morphine
- Detection Positive: 2-3 days
- Analytes: Codeine, Hydromorphone
- Tapentadol (Nucynta)
- Detection Positive: 1 to 5 days
- Analytes: Tapentadol O-Sulfate
- Tramadol
- Detection Positive: 2-4 days
- Analytes: Nortramadol
- Buprenorphine (by specific reference testing)
- Detection at up to 11 days
- Analytes include Norbuprenorphine
- Codeine
-
False Positives
- Chlorpromazine (Methadone)
- Clomipramine (Methadone)
- Dextromethorphan (Codeine or Morphine)
- Diphenhydramine (Methadone)
- Doxylamine (Methadone)
- Fluoroquinolones (esp. Ofloxacin, Levofloxacin positive for Codeine or Morphine)
- Poppy seeds (requires very high concentration, unlikely to occur with typical food intake)
- Quetiapine (Methadone)
- Quinine (Codeine or Morphine)
- Quinolones
- Rifampin (Codeine or Morphine)
- Thioridazine (Methadone)
- Verapamil (Methadone)
XIV. Preparations: Hallucinogenics - PCP (Phencyclidine)
- Detection
- Positive: 2 to 8 days (may persist as long as 14-28 days in some cases of chronic use)
- Causes: False Positive tests
XV. Preparations: Marijuana (THC metabolite, Cannabinoids)
-
General
- Marijuana is lipophilic and is detectable for long periods after last use
- Synthetic Marijuanas are not positive on Urine Drug Screens
- Second hand Marijuana smoke does not cause a positive result (50 ng/ml or more)
- Positive test would require extreme exposures at high room concentrations
- Cone (2015) J Anal Toxicol 39(1): 1-12 [PubMed]
- Analytes
- 11-nor-9-carboxy-Tetrahydrocannabinol
- Detection
- Positive Urine
- Single use: 2 days (up to 7 days)
- Use 3-4 times per week: 7 days (up to 14 days)
- Used Daily: 2 to 4 weeks
- Long-term, heavy use: 4-6 weeks (up to 12 weeks)
- Positive Blood: 8 hours
- Positive Urine
- Causes: False Positive tests
- Dronabinol (Marinol)
- Cannabidiol (CBD) if impure (e.g. trace amounts of THC)
- NSAIDS (especially Ibuprofen, Naproxen, Sulindac)
- Hemp containing foods
- Proton Pump Inhibitors (e.g. Pantoprazole)
- Efavirenz (Sustiva)
XVI. Preparations: Miscellaneous Agents
-
Methaqualone (Quaalude)
- Positive: 2 weeks
-
Rohypnol
- Positive: 72 hours
- GHB
- Positive: 6-12 hours
-
Soma
- Detected as Meprobamate (metabolite)
XVII. Causes: Adulterants that prevent drug detection in urine
- Acetic Acid (Vinegar)
- Decreases Test Sensitivity for Tetrahydrocannabinol (THC)
- Ammonia
- Masks detection of benzoylecgonine and Phencyclidine
- Benzalkonium chloride (Visine eye drops)
- Decreases Test Sensitivity for Tetrahydrocannabinol (THC)
-
Diuretics with water intake
- Dilutes urine to undetectable substance concentrations
- Sodium Hypochlorite (Bleach)
- Masks immunoassay and may also breakdown metabolites for gas chromatography
- Glutaraldehyde (Urinaid, Clean-X)
- Decreases immunoassay Test Sensitivity for several substances
- Goldenseal (Hydrastis canadensis)
- Herbal Diuretic that dilutes urine and decreases immunoassay sensitivity to Amphetamines, THC
-
Potassium Nitrite (Klear or Whizzies)
- Decreases immunoassay, gas chromatography, mass spectrometry Test Sensitivity
- Pyridium chlorochromate (Urine Luck, Instant Clean Add-it-ive)
- Oxidizing Agent that decreases immunoassay, gas chromatography, mass spectrometry sensitivity
- Powdered urine (Dry human urine residue)
- Substitutes a clean urine for the patient's urine
- Peroxide and Peroxidase (Stealth)
- Masks immunoassay for THC and Opioids
- Other agents used
- References
XVIII. Costs
- Typical screening immunoassay costs $128 ($62 to $308)
- Insurance coverage is variable
XIX. Resources
- Clinical Drug Testing in Primary Care
XX. References
- (2014) PL Detail-Document, Urine Drug Testing, Prescriber's Letter
- Jaffee (2007) J Subst Abuse Treat 33(1): 33-42 [PubMed]
- Kale (2019) Am Fam Physician 99(1):33-9 [PubMed]
- Moeller (2008) Mayo Clin Proc 83(1): 66-76 [PubMed]
- Smith (2016) Clin Lab Med 36(4):663-71 [PubMed]
- Standridge (2010) Am Fam Physician 81(5): 635-40 [PubMed]
Images: Related links to external sites (from Bing)
Related Studies
Concepts | Laboratory Procedure (T059) |
SnomedCT | 310627008 |
LNC | 12286-1 |
Dutch | urine geneesmiddelscreening |
French | Dépistage urinaire de drogues |
German | Drogenscreening im Urin |
Italian | Ricerca di farmaco/droga nelle urine |
Portuguese | Teste de fármacos na urina |
Spanish | Analítica toxicológica urinaria, cribaje mediante la detección de fármacos en orina, pesquisa de fármacos en orina, rastreo mediante la detección de fármacos en orina, tscreening de fármacos en orina, tamizaje de fármacos en orina, cribado mediante la detección de fármacos en orina (procedimiento), tamizaje mediante la detección de fármacos en orina, cribado mediante la detección de fármacos en orina, detección selectiva de fármacos en orina (procedimiento), screening mediante la detección de fármacos en orina, cribado de fármacos en orina, detección selectiva de fármacos en orina, pesquisa mediante la detección de fármacos en orina |
Japanese | 尿中薬物スクリーニング, ニョウチュウヤクブツスクリーニング |
English | urine drug screens, urine drug screens (lab test), Drugs identified:Prid:Pt:Urine:Nom:Screen, Drugs identified in Urine by Screen method, Drugs Ur Scn, drug screen urine, drug screening urine, drug screens urine, urine drug screening, drugs screen urine, drugs screened urine, urine drug screen, Drugs identified:Presence or Identity:Point in time:Urine:Nominal:Screen, Urine drug screening (procedure), Urine drug screening, Urine drug screen |
Czech | Test moči na přítomnost léku |
Hungarian | Vizelet gyógyszer szűrés |
Ontology: Toxicology screen, general (procedure) (C0430054)
Concepts | Laboratory Procedure (T059) |
SnomedCT | 171334006, 148548005, 69200006 |
LNC | LP6503-9 |
English | Poison screen, Toxicology screen, general (procedure), Toxicology screen, Screen, poisoning screening, toxicology screen, screen toxicology, screening toxicology, toxicology screening, screens toxicology, Toxicology screening (procedure), Toxicology screening, Toxicology screen, general, Poison screening, Toxicology screen, general, NOS |
Spanish | tamizaje de tóxicos, general, detección selectiva de tóxicos, general (procedimiento), cribado de tóxicos, general, detección selectiva de tóxicos, general |